AVAC Technology
Optical Reader & Particle Counter
The plasmonic nanoparticles are optically detected by measuring the weak scattering signal with proprietary dark-field micro-spectrophotometry. (Patents EP19382244, EP19382245)
Single Particle Digital Counting
As each plasmonic nanoparticle binds specifically to a biomarker of interest, by classifying and counting the different nanoparticles it is possible to quantify the amount of each biomarker immobilized on the substrate. (pending EP19382245, EP19382244)
Performance
High sensitivity in the femtogram range has been demonstrated for different biomarkers
Oncology
PSA, biomarker for prostate cancer recurrence detection.
Cardiac diseases
Troponin I, biomarker of reference for Myocardial Infarction.
Infectious diseases
P24 Biomarker for VIH detection.
Interleukin biomarkers (IL-10, IL-6, TNF-α)
Mecwins Total PSA Immunoassay
AVAC Technical Specifications 
| Spatial resolution | Reading/Analysis Speed | Throughput | Multiplexing Capability | User interface | Computer | Weight | Dimensions (H x D x W) |
|---|---|---|---|---|---|---|---|
| 0.7 µm (Diffraction-limited) | Up to 20000 images per hour | 96 samples in less tan 5 minutes | Up to 5 biomarkers | Integrated 15’’ touch screen for all in- and outputs | Fully integrated high-performance computer | 95 Kg | 750 mm x 735 mm x 520 mm |
